Literature DB >> 15928020

Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.

Shinya Yamaguchi1, Hiroshi Katahira, Sachihiko Ozawa, Yoko Nakamichi, Toshiaki Tanaka, Tatsuhiro Shimoyama, Kazuto Takahashi, Katsuhiko Yoshimoto, Mica Ohara Imaizumi, Shinya Nagamatsu, Hitoshi Ishida.   

Abstract

To determine whether the increase in glucose uptake following AMP-activated protein kinase (AMPK) activation in adipocytes is mediated by accelerated GLUT4 translocation into plasma membrane, we constructed a chimera between GLUT4 and enhanced green fluorescent protein (GLUT4-eGFP) and transferred its cDNA into the nucleus of 3T3-L1 adipocytes. Then, the dynamics of GLUT4-eGFP translocation were visualized in living cells by means of laser scanning confocal microscopy. It was revealed that the stimulation with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) and 2,4-dinitrophenol (DNP), known activators of AMPK, promptly accelerates its translocation within 4 min, as was found in the case of insulin stimulation. The insulin-induced GLUT4 translocation was markedly inhibited after addition of wortmannin (P < 0.01). However, the GLUT4 translocation through AMPK activators AICAR and DNP was not affected by wortmannin. Insulin- and AMPK-activated translocation of GLUT4 was not inhibited by SB-203580, an inhibitor of p38 mitogen-activated protein kinase (MAPK). Glucose uptake was significantly increased after addition of AMPK activators AICAR and DNP (P < 0.05). AMPK- and insulin-stimulated glucose uptake were similarly suppressed by wortmannin (P < 0.05-0.01). In addition, SB-203580 also significantly prevented the enhancement of glucose uptake induced by AMPK and insulin (P < 0.05). These results suggest that AMPK-activated GLUT4 translocation in 3T3-L1 adipocytes is mediated through the insulin-signaling pathway distal to the site of activated phosphatidylinositol 3-kinase or through a signaling system distinct from that activated by insulin. On the other hand, the increase of glucose uptake dependent on AMPK activators AICAR and DNP would be additionally due to enhancement of the intrinsic activity in translocated GLUT4 protein, possibly through a p38 MAPK-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928020     DOI: 10.1152/ajpendo.00456.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  41 in total

1.  Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection.

Authors:  Diana M Dunn; Irene Rodriguez-Sanchez; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

2.  Long-term ethanol exposure inhibits glucose transporter 4 expression via an AMPK-dependent pathway in adipocytes.

Authors:  Li Feng; Yong-feng Song; Qing-bo Guan; Hong-jun Liu; Bo Ban; Hai-xin Dong; Xiao-lei Hou; Kok-onn Lee; Ling Gao; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2010-02-22       Impact factor: 6.150

3.  What we have learnt about PIKE from the knockout mice.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  Int J Biochem Mol Biol       Date:  2011-06-07

4.  Golgin-160 is required for the Golgi membrane sorting of the insulin-responsive glucose transporter GLUT4 in adipocytes.

Authors:  Dumaine Williams; Stuart W Hicks; Carolyn E Machamer; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2006-10-18       Impact factor: 4.138

5.  E3 ubiquitin ligase, WWP1, interacts with AMPKα2 and down-regulates its expression in skeletal muscle C2C12 cells.

Authors:  Jung Ok Lee; Soo Kyung Lee; Nami Kim; Ji Hae Kim; Ga Young You; Ji Wook Moon; Sha Jie; Su Jin Kim; Yong Woo Lee; Ho Jin Kang; Yongchul Lim; Sun Hwa Park; Hyeon Soo Kim
Journal:  J Biol Chem       Date:  2013-01-04       Impact factor: 5.157

6.  Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK.

Authors:  Feng Zou; Xian-qing Mao; Nian Wang; Jian Liu; Jing-ping Ou-Yang
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

7.  A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics.

Authors:  Theresa S Moser; Russell G Jones; Craig B Thompson; Carolyn B Coyne; Sara Cherry
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

8.  Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice.

Authors:  M H Mooney; S Fogarty; C Stevenson; A M Gallagher; P Palit; S A Hawley; D G Hardie; G D Coxon; R D Waigh; R J Tate; A L Harvey; B L Furman
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

9.  Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.

Authors:  Honglin Hu; Min Xu; Renjuan Qi; Youmin Wang; Changjiang Wang; Jiongjiong Liu; Li Luo; Li Xia; Zhaohui Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance.

Authors:  Chi Bun Chan; Xia Liu; Dae Young Jung; John Y Jun; Hongbo R Luo; Jason K Kim; Keqiang Ye
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.